AbbVie Inc. - Common Stock (ABBV) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ABBV on NYSE
Shares outstanding
1,767,364,935
Price per share
$228.49
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,268,370,023
Total reported value
$293,414,989,502
% of total 13F portfolios
0.26%
Share change
-18,804,589
Value change
-$3,159,381,886
Number of holders
3,850
Price from insider filings
$228.49
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AbbVie Inc. - Common Stock (ABBV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $32,904,227,684 177,266,703 The Vanguard Group 30 Jun 2025

As of 30 Sep 2025, 3,850 institutional investors reported holding 1,268,370,023 shares of AbbVie Inc. - Common Stock (ABBV). This represents 72% of the company’s total 1,767,364,935 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AbbVie Inc. - Common Stock (ABBV) together control 46% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 177,747,261 +0.25% 0.62% $41,155,600,812
BlackRock, Inc. 8.3% 145,977,089 -1% 0.6% $33,799,535,063
STATE STREET CORP 4.5% 79,821,657 -0.25% 0.64% $18,481,906,462
JPMORGAN CHASE & CO 3.2% 56,534,816 -1.2% 0.83% $13,090,131,914
MORGAN STANLEY 2.4% 41,654,784 -0.11% 0.58% $9,644,749,545
GEODE CAPITAL MANAGEMENT, LLC 2.3% 40,439,493 +3.2% 0.6% $9,333,681,014
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.5% 25,958,106 -3.1% 0.96% $6,008,458,551
Capital Research Global Investors 1.4% 25,230,830 -0.14% 1.1% $5,841,881,609
BANK OF AMERICA CORP /DE/ 1.4% 25,154,905 +0.18% 0.44% $5,824,366,747
NORTHERN TRUST CORP 1.2% 22,046,227 +0.15% 0.65% $5,104,583,401
FMR LLC 1.2% 21,035,087 +0.16% 0.25% $4,870,464,147
FRANKLIN RESOURCES INC 0.82% 14,551,400 -3.7% 0.84% $3,369,230,980
GOLDMAN SACHS GROUP INC 0.76% 13,395,219 +10% 0.45% $3,101,529,160
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.71% 12,581,121 -14% 0.63% $2,913,032,756
Bank of New York Mellon Corp 0.7% 12,301,919 -1.6% 0.51% $2,848,386,477
Legal & General Group Plc 0.68% 12,004,084 +4.3% 0.62% $2,779,425,606
UBS Group AG 0.66% 11,718,236 -0.73% 0.53% $2,713,240,363
Capital International Investors 0.61% 10,703,532 -22% 0.4% $2,476,737,567
PRICE T ROWE ASSOCIATES INC /MD/ 0.6% 10,602,227 +17% 0.26% $2,454,841,000
WELLINGTON MANAGEMENT GROUP LLP 0.6% 10,536,901 +457% 0.43% $2,439,714,057
Amundi 0.59% 10,508,317 +16% 0.78% $2,418,909,492
AMERIPRISE FINANCIAL INC 0.55% 9,675,877 +4.4% 0.52% $2,241,362,587
RAYMOND JAMES FINANCIAL INC 0.54% 9,557,701 +2.4% 0.71% $2,212,110,461
DEUTSCHE BANK AG\ 0.54% 9,456,032 +3% 0.73% $2,189,449,648
WELLS FARGO & COMPANY/MN 0.52% 9,127,140 +0.93% 0.43% $2,113,297,880

Institutional Holders of AbbVie Inc. - Common Stock (ABBV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 24,968,486 $5,697,235,004 -$24,281,932 $228.49 569
2025 Q3 1,268,370,023 $293,414,989,502 -$3,159,381,886 $231.54 3,850
2025 Q2 1,287,075,518 $238,891,433,790 +$4,866,082,603 $185.62 3,742
2025 Q1 1,261,493,107 $264,023,235,689 -$2,130,141,483 $209.52 3,780
2024 Q4 1,275,092,654 $226,558,537,921 +$1,209,556,751 $177.70 3,709
2024 Q3 1,263,246,128 $249,268,364,641 +$88,413,171 $197.48 3,466
2024 Q2 1,262,725,926 $216,474,972,193 +$1,915,850,329 $171.52 3,339
2024 Q1 1,253,088,393 $227,875,219,935 +$2,788,759,396 $182.10 3,353
2023 Q4 1,239,748,668 $192,192,568,041 +$1,517,401,072 $154.97 3,297
2023 Q3 1,228,903,942 $183,197,476,249 +$1,009,113,820 $149.06 3,092
2023 Q2 1,221,315,614 $164,787,374,519 -$1,664,070,544 $134.73 3,053
2023 Q1 1,233,425,991 $196,519,460,228 +$259,081,467 $159.37 3,117
2022 Q4 1,235,502,434 $199,621,628,438 +$2,752,393,686 $161.61 3,144
2022 Q3 1,221,220,466 $164,097,646,774 +$170,284,213 $134.21 2,949
2022 Q2 1,217,745,031 $186,477,353,594 +$3,489,007,770 $153.16 2,980
2022 Q1 1,203,308,144 $195,040,563,504 +$2,450,810,000 $162.11 3,033
2021 Q4 1,188,323,728 $160,862,723,207 +$1,040,998,406 $135.40 2,954
2021 Q3 1,177,170,536 $127,005,644,713 -$384,320,770 $107.87 2,641
2021 Q2 1,182,050,895 $133,115,260,852 -$647,210,591 $112.64 2,657
2021 Q1 1,186,224,948 $128,344,178,557 -$1,087,268,478 $108.22 2,595
2020 Q4 1,197,885,694 $128,301,295,744 -$1,070,454,735 $107.15 2,580
2020 Q3 1,210,244,308 $105,941,681,033 -$1,507,877,911 $87.59 2,356
2020 Q2 1,226,149,387 $120,286,919,217 +$14,394,795,664 $98.18 2,397
2020 Q1 1,079,313,793 $82,241,542,825 +$791,234,318 $76.19 2,213
2019 Q4 1,067,427,836 $94,486,529,954 +$1,223,798,676 $88.54 2,231
2019 Q3 1,056,424,195 $79,981,092,369 +$2,749,727,052 $75.72 1,995
2019 Q2 1,020,107,599 $74,140,080,434 +$134,418,416 $72.72 2,013
2019 Q1 1,025,594,398 $82,642,729,287 -$1,357,273,013 $80.59 2,023
2018 Q4 1,043,063,858 $96,057,755,521 -$2,268,195,432 $92.19 2,054
2018 Q3 1,064,303,780 $100,606,565,412 -$228,478,920 $94.58 1,952
2018 Q2 1,066,935,394 $98,824,334,101 -$4,621,865,658 $92.65 1,988
2018 Q1 1,115,897,507 $105,577,975,508 -$635,075,420 $94.65 2,010
2017 Q4 1,124,483,239 $108,727,093,427 +$374,684,079 $96.71 1,990
2017 Q3 1,118,458,594 $99,379,513,075 +$1,309,956,795 $88.86 1,792
2017 Q2 1,104,509,124 $80,068,623,904 +$1,082,850,124 $72.51 1,761
2017 Q1 1,097,772,439 $71,530,343,434 +$6,012,078,996 $65.16 1,725
2016 Q4 1,094,423,119 $68,517,301,870 -$1,501,669,878 $62.62 1,686
2016 Q3 1,115,082,886 $70,272,962,866 -$935,916,366 $63.07 1,642
2016 Q2 1,128,170,500 $69,822,885,108 +$1,331,070,628 $61.91 1,624
2016 Q1 1,107,228,663 $63,240,024,329 -$234,331,465 $57.12 1,624
2015 Q4 1,114,783,288 $66,029,826,303 -$1,761,226,133 $59.24 1,627
2015 Q3 1,135,736,480 $61,795,060,747 -$3,097,342,097 $54.41 1,586
2015 Q2 1,197,000,259 $80,428,666,659 +$5,904,487,622 $67.19 1,642
2015 Q1 1,111,667,985 $65,099,745,699 -$591,285,996 $58.54 1,590
2014 Q4 1,121,324,839 $73,375,310,991 -$8,392,175,216 $65.44 1,596
2014 Q3 1,252,517,869 $72,342,438,122 +$8,158,820,153 $57.76 1,493
2014 Q2 1,110,338,015 $62,659,470,218 +$2,575,063,702 $56.44 1,448
2014 Q1 1,066,968,421 $54,829,249,328 +$103,303,847 $51.40 1,413